Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer

[1]  M. Furihata,et al.  A rare case of coexistence of pulmonary adenocarcinoma with Langerhans’ cell histiocytosis , 2008, Medical Molecular Morphology.

[2]  J. Vansteenkiste.  PET scan in the staging of non-small cell lung cancer. , 2003, Lung cancer.

[3]  B. Passlick.  Initial surgical staging of lung cancer. , 2003, Lung cancer.

[4]  L. Molins,et al.  Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer. A prospective study of 105 patients. , 2003, Lung cancer.

[5]  G. Scagliotti,et al.  Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. , 2003, Lung cancer.

[6]  Thomas Beyer,et al.  Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.

[7]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[8]  Arnulf H Hölscher,et al.  Lymph node size and metastatic infiltration in non-small cell lung cancer. , 2003, Chest.

[9]  O. Prante,et al.  Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Hiroto Hatabu,et al.  Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. , 2002, European journal of radiology.

[11]  Y. Ohno,et al.  MR imaging of lung cancer. , 2002, European journal of radiology.

[12]  R. Tsuchiya,et al.  Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. , 2001, Lung cancer.

[13]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[14]  N Cascinelli,et al.  Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Y. Nishiwaki,et al.  Clinical predictors of N2 disease in non-small cell lung cancer. , 2000, Chest.

[16]  N. Gupta,et al.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 3 cm) lymph node lesions. , 2000 .

[17]  Y. Nishiwaki,et al.  Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.

[18]  G. Graeber,et al.  Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. , 1999, Annals of surgery.

[19]  R Weissleder,et al.  Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  S. Reske,et al.  Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). , 1997, Thorax.

[21]  T. Matsumoto,et al.  Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. , 1996, Chest.

[22]  H. Ishida,et al.  Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. , 1994, The Journal of thoracic and cardiovascular surgery.

[23]  T. Ido,et al.  Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[25]  J. Mate,et al.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. , 1994, The New England journal of medicine.

[26]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  H. Kinoshita,et al.  Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastasis , 1992, World Journal of Surgery.

[28]  K. Kerr,et al.  Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. , 1992, Thorax.

[29]  E H Moore,et al.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.

[30]  B J McNeil,et al.  CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. , 1991, Radiology.

[31]  K. Sugimachi,et al.  Surgical treatment of patients with nonsmall‐cell lung cancer and mediastinal lymph node involvement , 1990, Journal of surgical oncology.

[32]  S Sone,et al.  The number and size of normal mediastinal lymph nodes: a postmortem study. , 1988, AJR. American journal of roentgenology.

[33]  F L Bookstein,et al.  Mediastinal lymph node detection and sizing at CT and autopsy. , 1986, AJR. American journal of roentgenology.

[34]  F L Bookstein,et al.  Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.

[35]  G. Genereux,et al.  Normal mediastinal lymph node size and number: CT and anatomic study. , 1984, AJR. American journal of roentgenology.

[36]  J. Erikssen,et al.  [Treatment of thyrotoxicosis with thyreostatics. A prospective study of 105 patients]. , 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[37]  G. Silvestri,et al.  Lung cancer. Invasive staging: the guidelines. , 2003, Chest.

[38]  G. Silvestri,et al.  Invasive staging: The guidelines , 2003 .